Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases.

Sponsor
University of Thessaly
Study ID
NCT07380022
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Dietary supplement intervention Goodphyte IB Defense — DIETARY_SUPPLEMENT
    Participants will receive orally Goodphyte IB Defense at a dose of four capsules per day for a duration of two weeks.
  • Dietary supplement intervention Goodphyte Immunity — DIETARY_SUPPLEMENT
    Participants will receive orally Goodphyte IB Immunity at a dose of four capsules per day for a duration of two weeks.

Study Details

The primary objective of the present postdoctoral research is to evaluate the acceptability and adherence of two dietary supplements containing microbial phytase, Goodphyte IB Defense and Goodphyte Immunity, in adult individuals with chronic diseases, namely Idiopathic Inflammatory Bowel Diseases (IIBD)-that is, Crohn's disease (CD) or Ulcerative Colitis (UC)-Arterial Hypertension (AH), Anemia (AN), or Multiple Sclerosis (MS). Secondarily, this study will investigate potential changes in iron and zinc absorption following phytase supplementation in these individuals and, consequently, possible changes in their quality of life.

Key Dates

Start date
Jul 9, 2025
Status verified
Jan 2026
Primary completion
Feb 28, 2026
Completion
Feb 28, 2026

Study Design

Enrollment
100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Other: Dietary supplement intervention Goodphyte IB Defense
    50 Participants will receive dietary supplement Goodphyte IB Defense
  • Other: Dietary supplement intervention Goodphyte Immunity
    50 Participants will receive dietary supplement Goodphyte Immunity

Primary Outcome Measure

Acceptability of two dietary supplements containing microbial phytase, Goodphyte IB Defense and Goodphyte Immunity using an acceptability questionnaire [ Time Frame: 2 weeks (immediately after completion of the 2-week intervention) ]

Central Contacts

Related Studies